Uploaded January 2025 | Updated September 2026, 2 hours ago
On December 12-13, 2024, the National Human Genome Research Institute (NHGRI) and the National Institute of Allergy and Infectious Diseases (NIAID) co-sponsored the 16th Genomic Medicine meeting, Host Genomics and Infectious Disease: Opportunities for Implementing Genomic Medicine, in Bethesda MD. The meeting aimed to identify needs, opportunities, and challenges for applying a patient’s genomic information (genome sequence, transcriptomic, epigenomic, etc. data) in the diagnosis, prevention, and treatment of infectious diseases. Persistent barriers and evidence gaps were examined as opportunities for additional research.
Agenda: genome.gov/GM16
Chapters:
00:00 - Start
00:15 - Recap of Day 1 (Geoffrey Ginsburg)
07:36 - Aminoglycosides, Clinical Settings and PGx Variants Mediate Drug-Induced Hearing Loss (Peter Steyger)
23:01 - From Theory to Practice: Navigating Strategies and Barriers in the Clinical Implementation of Voriconazole Pharmacogenetics (Aniwaa Owusu Obeng)
38:52 - Unique Challenges with Implementing G6PD Genetic Testing to Prevent Drug-Induced Hemolytic Anemia (Roseann Donnelly)
52:08 - Pharmacogenetics of Antiviral Agents (David Haas)
01:07:24 - Sesson 5 Discussion
On December 12-13, 2024, the National Human Genome Research Institute (NHGRI) and the National Institute of Allergy and Infectious Diseases (NIAID) co-sponsored the 16th Genomic Medicine meeting, Host Genomics and Infectious Disease: Opportunities for Implementing Genomic Medicine, in Bethesda MD. The meeting aimed to identify needs, opportunities, and challenges for applying a patient’s genomic information (genome sequence, transcriptomic, epigenomic, etc. data) in the diagnosis, prevention, and treatment of infectious diseases. Persistent barriers and evidence gaps were examined as opportunities for additional research.
Agenda: genome.gov/GM16
Chapters:
00:00 - Start
00:15 - Recap of Day 1 (Geoffrey Ginsburg)
07:36 - Aminoglycosides, Clinical Settings and PGx Variants Mediate Drug-Induced Hearing Loss (Peter Steyger)
23:01 - From Theory to Practice: Navigating Strategies and Barriers in the Clinical Implementation of Voriconazole Pharmacogenetics (Aniwaa Owusu Obeng)
38:52 - Unique Challenges with Implementing G6PD Genetic Testing to Prevent Drug-Induced Hemolytic Anemia (Roseann Donnelly)
52:08 - Pharmacogenetics of Antiviral Agents (David Haas)
01:07:24 - Sesson 5 Discussion
